hypercalcemia

Search with Google Search with Bing
Information
Disease name
hypercalcemia
Disease ID
DOID:12678
Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
Genes Mutation Description Source Links
NCT ID Status Phase Summary Start date Completion date
NCT00001277 Completed Phase 2 Studies of Elevated Parathyroid Activity December 15, 1993 December 23, 2020
NCT00126386 Completed N/A Zometa for the Management of Tumor-induced Hypercalcemia and Malignant Bone Pain in the Community January 2004 September 2006
NCT00325104 Completed Phase 3 Cinacalcet to Treat Familial Primary Hyperparathyroidism May 9, 2006 March 31, 2007
NCT00485706 Completed N/A Arterial Stiffness and Decreased Bone Buffering Capacity in Hemodialysis Patients June 2007
NCT00581828 Completed Phase 4 Does Treatment of Hypovitaminosis D Increase Calcium Absorption? January 2005 December 2008
NCT00674154 Completed Phase 2/Phase 3 Effect of Vitamin D Treatment in Primary Hyperparathyroidism May 2008 August 2013
NCT00744302 Completed Phase 2 Study of 1.25 mmol/L Calcium Dialysate on Mineral Metabolism in Haemodialysis Patients. April 2006 December 2009
NCT00891813 Completed Phase 4 Effectiveness and Safety of IV Zemplar in Patients on Hemodialysis and With Secondary Hyperparathyroidism Using iPTH/100 as Initial Dose May 2009 September 2010
NCT00975221 Completed Phase 3 Efficacy and Safety Study of Cinacalcet for the Treatment of Hypercalcemia in Patients With Primary Hyperparathyroidism Unable to Undergo Parathyroidectomy March 10, 2010 December 21, 2012
NCT01042626 Completed N/A Oral Peptones Load in Normocalcemic and Hypercalcemic Primary Hyperparathyroidism and Healthy Subjects July 2004 January 2005
NCT01460030 Completed Phase 3 An Intra-individual Titration Study of KRN1493 for the Treatment of Hypercalcemia in Patients With Parathyroid Carcinoma or Intractable Primary Hyperparathyroidism November 2011 February 2013
NCT02908542 Completed Search for New Genetic Causes of Hypercalcemia by Massively Parallel Sequencing of a Genes Panel December 2015 December 2018
NCT04256369 Completed Rate of Termination of Premixed Parenteral Nutrition (PN) in Surgical Patients Secondary to High Serum Electrolytes February 2, 2020 December 30, 2021
NCT04299425 Completed N/A Evaluating Impact of NIRAF Detection for Identifying Parathyroid Glands During Parathyroidectomy March 13, 2020 March 3, 2023
NCT05022641 Recruiting N/A Evaluating Impact of Near Infrared Autofluorescence (NIRAF) Detection for Identifying Parathyroid Glands During Parathyroidectomy December 1, 2021 August 2024
NCT04265599 Recruiting Exploring Pathogenesis and Treatment of Hypercalcemia Caused by Intramuscular Injection of Paraffinoil April 30, 2019 January 31, 2025
NCT05152927 Recruiting N/A Near Infrared Autofluorescence (NIRAF) Detection for Identifying Parathyroid Glands During Parathyroidectomy January 10, 2022 January 31, 2025
NCT05585593 Recruiting Registry for Hypoparathyroidism Wuerzburg October 18, 2017 January 1, 2032
NCT04292288 Recruiting Hypercalcemia After Paraffin Oil Injection April 1, 2019 January 1, 2028
NCT00415584 Terminated Phase 1/Phase 2 Cinacalcet to Treat Hypercalcemia in Renal Transplant Recipients January 2007 November 2009
NCT01725113 Terminated Phase 4 Management of Mineral and Bone Disease in Hemodialysis-Calcitriol vs. Paricalcitol November 2012 October 2015
NCT03935984 Unknown status Phase 4 Calcitonin Pre-treatment to Improve SPECT-CT Sensitivity May 29, 2019 October 1, 2021
NCT01647503 Unknown status Differentially Expressed Proteins in Sporadic Parathyroid Tumors July 2012
NCT01021280 Unknown status Parathyroid Hormone (PTH) Homeostasis in Bartter Syndrome January 2013 June 2014
NCT01226810 Unknown status The Novel Approach of Minimally Invasive Parathyroid Surgery Requires Precise Identification and Localization of the Lesion Prior to Exploration January 2011
NCT02711059 Withdrawn N/A Insulin Resistance in Primary Hyperparathyroidism October 2015 June 2022
NCT03516747 Withdrawn N/A Preoperational Fine Needle Aspiration of Pathological Parathyroid Gland June 9, 2018 August 9, 2020
NCT01329666 Withdrawn Phase 2/Phase 3 Primary Hyperparathyroidism (PHPT): Early Effect of Vitamin D May 2010 January 2015
Disase is a (Disease Ontology)
DOID:10575
Cross Reference ID (Disease Ontology)
ICD10CM:E83.52
Cross Reference ID (Disease Ontology)
ICD9CM:275.42
Cross Reference ID (Disease Ontology)
MESH:D006934
Cross Reference ID (Disease Ontology)
SNOMEDCT_US_2023_03_01:154752005
Cross Reference ID (Disease Ontology)
UMLS_CUI:C0020437
HPO Human Phenotype ID (Human Phenotype Ontology)
HP:0003072
MeSH unique ID (MeSH (Medical Subject Headings))
D006934